Currently Viewing:
Currently Reading
ELOQUENT-3: Adding Elotuzumab to Pomalidomide, Dexamethasone Improves PFS in R/R Multiple Myeloma
December 08, 2018 – David Bai, PharmD
Studies Show Medicaid Expansion Is Improving Health, While Jury Still Out on Chronic Disease
December 07, 2018 – Mary Caffrey
Continuous Infusion of Recombinant Activated Factor VII Safe, Effective in Management of Congenital Hemophilia
December 07, 2018 – Jackie Syrop
Study Identifies COPD Patient Subgroup Who Benefit Most From Roflumilast
December 07, 2018 – Alison Rodriguez
Researchers Demonstrate Efficacy of EEG-Based Test for Measuring Pain
December 07, 2018 – Alison Rodriguez
European Stakeholders Appeal EPO Ruling to Uphold Gilead's Sofosbuvir Patent
December 07, 2018 – Samantha DiGrande
5 Things to Know About Getting the Flu Shot
December 07, 2018 – Samantha DiGrande
CMS Finalizes Risk-Adjustment Rule for 2018 Benefit Year
December 07, 2018 – Allison Inserro
International Consensus on Timely Care for Multiple Sclerosis
December 07, 2018 – David Bai, PharmD

Only Some Chronic Diseases Benefit from Disease Management Program

Laura Joszt
A disease management program at the University of Minnesota revealed only some targeted chronic diseases benefitted from the program while others were unaffected.
A disease management (DM) program at the University of Minnesota only some targeted chronic diseases benefitted from the program while others were unaffected, according to a study published in the Journal of Occupational & Environmental Medicine.

Eric Jutkowitz, BA, and colleagues evaluated the impact of the DM program for individuals with common, high-cost chronic diseases, such as asthma, cardiovascular disease, congestive heart failure, diabetes, and migraine headaches, to determine the effect of participation on expenditures, absenteeism, hospitalizations, and avoidable hospitalizations.

The university program, which relied on disease-specific telephone coaching, reduced costs for most targeted conditions over a 6-year period, according to the findings. In particular, healthcare spending decreased for asthma, cardiovascular disease, congestive heart failure, depression, musculoskeletal disorders, low back pain, and migraine headaches. However, the program did not affect absenteeism for any of the targeted conditions.

"Employers should focus on those conditions that generate savings when purchasing DM programs," the authors suggested.

The researchers believed their DM approach partly lowered costs by reducing "management breakdowns" that led to avoidable hospitalizations. In particular, the DM program reduced avoidable hospitalizations for patients with asthma, depression, and low back pain.

According to the findings, the DM program also reduced overall hospitalizations for those 3 conditions, as well as cardiovascular disease, musculoskeletal problems, and migraines. Although the program did reduce healthcare expenditures for individuals with congestive heart failure, it did not reduce hospitalizations.

The program had not effect for individuals with diabetes, arthritis, or osteoporosis. However, the authors note that while the University of Minnesota's DM program did not reduce costs and hospitalizations for diabetes, other DM programs have reported reductions in diabetes costs.

Diabetes patients could really benefit from some intervention that reduces cost of care. A recent study published in Diabetes Care found that the cost of diabetes has more than doubled in the last 20 years. While medications account for 55% of the increase in spending, the researchers found 24% was attributed to inpatient visits, 15% to outpatient visits, and 6% to emergency room visits and other medical spending.

Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!